Comparative Pharmacology
Head-to-head clinical analysis: CORDRAN N versus HC 1.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CORDRAN N versus HC 1.
CORDRAN N vs HC #1
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cordran N contains flurandrenolide, a corticosteroid that exerts anti-inflammatory, antipruritic, and vasoconstrictive actions by inducing phospholipase A2 inhibitory proteins (lipocortins) and modulating gene expression; neomycin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit.
Unknown
Apply sparingly to affected area 2-3 times daily. Use for no longer than 2 weeks.
Hydrocortisone: 100-200 mg IV as initial dose, then 50-100 mg IV every 6 hours, or 0.18 mg/kg/h IV continuous infusion.
None Documented
None Documented
Approximately 1-2 hours. Short half-life consistent with topical use; systemic exposure minimal with proper application.
2–4 hours (terminal); prolonged in renal impairment.
Primarily renal (biliary/fecal minimal). Unchanged drug and glucuronide metabolites excreted in urine.
Renal: 90% as unchanged drug; fecal: 10%.
Category C
Category C
Topical Corticosteroid + Antibiotic
Topical Corticosteroid